Laboratorios Richmond SACIF

Laboratorios Richmond SACIF ROCE

The Return on Capital Employed (ROCE) of Laboratorios Richmond SACIF (RICH.BA) as of Nov 21, 2026 is 24.21 %. In the previous year, Return on Capital Employed (ROCE) was 23.55 % — a change of 2.80% (higher).

ROCE

24.21 %

YoY

2.80%

Last updated:

In 2024, Laboratorios Richmond SACIF's return on capital employed (ROCE) was 24.21 %, a 2.80% increase from the 23.55 % ROCE in the previous year.

The Laboratorios Richmond SACIF ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2017
15.67 ARS
Jan 1, 2018
10.69 ARS
Jan 1, 2019
38.08 ARS
Jan 1, 2020
45.63 ARS
Jan 1, 2021
43.56 ARS
Jan 1, 2022
29.44 ARS
Jan 1, 2023
23.55 ARS
Jan 1, 2024
24.21 ARS
The Laboratorios Richmond SACIF ROCE history
YEARROCEYoY
24.21 %+2.80%
23.55 %-20.02%
29.44 %-32.41%
43.56 %-4.54%
45.63 %+19.85%
38.08 %+256.30%
10.69 %-31.78%
15.67 %-87.66%
126.95 %+23.71%
102.62 %+62.67%
63.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Laboratorios Richmond SACIF's Return on Capital Employed (ROCE)

Laboratorios Richmond SACIF's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Laboratorios Richmond SACIF's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Laboratorios Richmond SACIF's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Laboratorios Richmond SACIF’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Return on Capital Employed (ROCE) of Laboratorios Richmond SACIF is 24.21 % in 2024.

Return on Capital Employed (ROCE) of Laboratorios Richmond SACIF changed from 23.55 % to 24.21 %, representing a 2.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Laboratorios Richmond SACIF with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF